NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

vTv lab photo
vTv Therapeutics of High Point has out-licensed worldwide development and commercialization rights to its potential kidney disease drug to a California biotech company in a deal that ultimately could be worth more than $150 million.
Durham Startup BioSkryb Launches Grants to Fund ‘Breakthrough’ in Single-Cell Genomics
Durham's BioSkryb is launching a grant program to secure a “breakthrough” in single-cell genomics using its proprietary technology, recently launched commercially as ResolveDNA.
Pixel kit
Burlington-based LabCorp has received Emergency Use Authorization from the FDA to sell its COVID-19 test home collection kit, the first to be available over the counter without requiring a prescription.
Vanilla beans Shutterstock
Durham gene editing ag tech leader Elo Life Systems is using its proprietary computational biology pipeline to identify the genetic factors that can improve the vanilla orchid and introduce groundbreaking ways to produce more vanilla with less labor.
Greenville expansion rendering
Thermo Fisher Scientific will invest approximately $500 million and add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines
Seqirus workers at Holly Springs vax facility
Newly released Seqirus data demonstrate the effectiveness and safety of its pandemic influenza A (H5N1) vaccine that it makes in cell culture at its massive manufacturing facility in Holly Springs.
In ovo injection system at Maxton facility
Southeastern North Carolina’s rural Scotland County community of Maxton is getting 10 new jobs and a $1.9 million expansion being added to the local Huvepharma factory, thanks in part to funding from NCBiotech.
Candida auris
Mycovia logo

Antifungal therapies developer Mycovia is preparing to seek FDA approval of its first drug after the compound posted

Chimerix logo
Chimerix, a Durham-based biopharmaceutical company that’s developing medicines to treat cancer and other diseases, has received good regulatory news for its potential antiviral treatment for smallpox.

BioCryst logoThe United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Durham-based BioCryst Pharmaceuticals’ berotralstat a positive scientific opinion through the Early Access to Medicines Scheme.

BioCryst drug Orladeyo
The FDA has approved a once-daily capsule developed by Durham's BioCryst Pharmaceuticals to prevent the life-threatening attacks of swelling in people with the rare disease called hereditary angioedema, or HAE.
Patriot Park site of KBI expansion
An NCBiotech contract drug development and manufacturing portfolio company, KBI Biopharma, will establish a new $150M, 200-employee manufacturing facility near RTP.
North Carolina’s Small Business and Technology Development Center is hosting a two-day workshop for entrepreneurs starting Wednesday, Dec. 2
James Siedow, Ph.D.
Former Duke University science educator and researcher and NCBiotech board member James (Jim) Siedow, Ph.D., has died. 
Amnion foundation logo
Academic scientists at NC universities receive the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.